IGC Pharma, Inc. Stock: price and insider trades · United States

This page follows insider dealings at IGC Pharma, Inc. as filed with SEC (Form 4), a company from the Health Care sector. 4 insiders have disclosed 15 filings since 23 October 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Compared with its exchange (2,023 companies, median 41 filings), a count of 15 filings is below the norm. Since 2016, the database holds 1 purchase and 36 sales by insiders of the company.

Insider buying of IGC Pharma, Inc. has been absent for the past year. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.